
Learn if AZEDRA
could be right for you
AZEDRA is the first and only approved treatment for advanced
pheochromocytoma and paraganglioma.
Not an actual patient.
Learn about pheochromocytoma and paraganglioma
Pheochromocytoma and paraganglioma are rare tumors that cause a variety of serious symptoms. Because they are unique tumors, the goals for treating them are also unique.
Learn what to expect with AZEDRA
AZEDRA was studied in the largest clinical trial of its kind for pheochromocytoma and paraganglioma. In the study, AZEDRA was proven to reduce the need for antihypertensive medication and control tumor growth.
Not an actual patient.
Find comprehensive pheochromocytoma and paraganglioma care near you
AZEDRA is offered at Centers of Excellence nationwide. Find an AZEDRA treatment site near you.
View patient resources and
find support services
Learn about the AZEDRA support program, explore
Frequently Asked Questions and a Glossary, and
download the AZEDRA Patient Brochure.